2.14. Analysis.
Comparison 2: Insulin glargine versus NPH insulin, Outcome 14: Non‐serious adverse events (published vs. unpublished data)
Comparison 2: Insulin glargine versus NPH insulin, Outcome 14: Non‐serious adverse events (published vs. unpublished data)